Home › Breast Carcinoma In Situ › Illinois › Chicago
Breast Carcinoma In Situ clinical trials in Chicago, IL
3 studies for Breast Carcinoma In Situ are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
RecruitingHealthy volunteers welcome
- University of Chicago, Chicago
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
RecruitingPhase 2
- Northwestern University, Chicago
- University of Illinois College of Medicine - Chicago, Chicago
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
RecruitingPhase 2
- Northwestern University, Chicago
Breast Carcinoma In Situ trials in other cities
- Columbus, OH5 studies
- Boston, MA4 studies
- Jacksonville, FL4 studies
- New York City, NY4 studies
- Philadelphia, PA3 studies
- Kansas City, KS3 studies
- Ann Arbor, MI3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer59 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer36 studies
- Colorectal Cancer34 studies
- Stroke34 studies
- Heart Failure31 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.